Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction:: Role of memory B cells and CD5+ B cells

被引:77
作者
Blanca, IR
Bere, EW
Young, HA
Ortaldo, JR
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Expt Immunol Lab, Frederick, MD 21702 USA
[2] Cent Univ Venezuela, Fac Med, Inst Inmunol, Caracas, Venezuela
关键词
D O I
10.4049/jimmunol.167.11.6132
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells are a subpopulation of lymphocytes characterized primarily by their cytolytic activity. They are recognized as an important component of the immune response against virus infection and tumors. In addition to their cytolytic activity, NK cells also participate either directly or indirectly in the regulation of the ongoing Ab response. More recently, it has been suggested that NK cells have an important role in the outcome of autoimmune diseases. Here, we demonstrate that human NK cells can induce autologous resting B cells to synthesize Ig, including switching to IgG and IgA, reminiscent of a secondary Ab response. B cell activation by the NK cell is contact-dependent and rapid, suggesting an autocrine B cell-regulated process. This NK cell function is T cell-independent, requires an active cytoplasmic membrane, and is blocked by anti-CD40 ligand (anti-CD154) or CD40-mIg fusion protein, indicating a critical role for CD40-CD40 ligand interaction. Depletion studies also demonstrate that CD5(+) B cells (autoreactive B-1 cells) and a heterogeneous population of CD27(+) memory B cells play a critical role in the Ig response induced by NK cells. The existence of this novel mechanism of B cell activation has important implications in innate immunity, B cell-mediated autoimmunity, and B cell neoplasia.
引用
收藏
页码:6132 / 6139
页数:8
相关论文
共 46 条
[11]  
Fehniger TA, 1999, J IMMUNOL, V162, P4511
[12]   Direct activation of porcine endothelial cells by human natural killer cells [J].
Goodman, DJ ;
VonAlbertini, M ;
Willson, A ;
Millan, MT ;
Bach, FH .
TRANSPLANTATION, 1996, 61 (05) :763-771
[13]  
GRAMMER AC, 1995, J IMMUNOL, V154, P4996
[14]  
GRAY JD, 1995, J IMMUNOL, V154, P5656
[15]   CD40 and CD154 in cell-mediated immunity [J].
Grewal, IS ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :111-135
[16]   NORMAL, AUTOIMMUNE, AND MALIGNANT CD5+ B-CELLS - THE LY-1-B LINEAGE [J].
HAYAKAWA, K ;
HARDY, RR .
ANNUAL REVIEW OF IMMUNOLOGY, 1988, 6 :197-218
[17]   NATURAL KILLER CELLS - CHARACTERISTICS AND REGULATION OF ACTIVITY [J].
HERBERMAN, RB ;
DJEU, JY ;
KAY, HD ;
ORTALDO, JR ;
RICCARDI, C ;
BONNARD, GD ;
HOLDEN, HT ;
FAGNANI, R ;
SANTONI, A ;
PUCCETTI, P .
IMMUNOLOGICAL REVIEWS, 1979, 44 :43-70
[18]  
Hoshino T, 1999, J IMMUNOL, V162, P5070
[19]  
Iwasaki T, 1998, CLIN EXP IMMUNOL, V114, P1
[20]   NATURAL-KILLER CELLS CAN ENHANCE THE PROLIFERATIVE RESPONSES OF LYMPHOCYTES-B [J].
KATZ, P ;
WHALEN, G ;
CUPPS, TR ;
MITCHELL, SR ;
EVANS, M .
CELLULAR IMMUNOLOGY, 1989, 120 (01) :270-276